We aim to create and represents a paradigm shift in stevia trading that harnesses the power of technology to provide trading transparency and to generate multi-million dollar productivity gains across the supply chain.
Company (Alive / Active)
|Title||Application Date||Patent Date||Status
(Patent / Application)
|Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or metabolic syndrome||Jun 13, 2013||May 02, 2017||Patent|